home / stock / agrx / agrx news


AGRX News and Press, Agile Therapeutics Inc.

Stock Information

Company Name: Agile Therapeutics Inc.
Stock Symbol: AGRX
Market: OTC
Website: agiletherapeutics.com

Menu

AGRX AGRX Quote AGRX Short AGRX News AGRX Articles AGRX Message Board
Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

AGRX - Agile Therapeutics to be acquired by Spain-based Insud for an enterprise value of ~$45M

2024-06-26 08:12:37 ET More on Agile Therapeutics Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript Financial information for Agile Therapeutics Read the full article on Seeking Alpha For further details see: Agile Therapeutics to be acquir...

AGRX - Agile Therapeutics Non-GAAP EPS of -$0.63, revenue of $5.7M

2024-05-15 16:58:52 ET More on Agile Therapeutics Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript Agile Therapeutics Q4 2023 Earnings Preview Agile Therapeutics announces delisting from Nasdaq Financial information for Agile Therapeutics ...

AGRX - Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...

AGRX - Expected US Company Earnings on Thursday, May 9th, 2024

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

AGRX - Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript

2024-03-28 10:46:06 ET Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Conference Call March 28, 2024 8:30 AM ET Company Participants Matt Riley - Head of Investor Relations and Corporate Communications Al Altomari - Chairman and Chief Executive Officer Presen...

AGRX - Agile Therapeutics reports Q4 results

2024-03-28 08:13:58 ET More on Agile Therapeutics Agile Therapeutics Q4 2023 Earnings Preview Agile Therapeutics announces delisting from Nasdaq Seeking Alpha’s Quant Rating on Agile Therapeutics Historical earnings data for Agile Therapeutics ...

AGRX - Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...

AGRX - Expected US Company Earnings on Thursday, March 28th, 2024

Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...

AGRX - Agile Therapeutics Q4 2023 Earnings Preview

2024-03-27 12:31:23 ET More on Agile Therapeutics Agile Therapeutics announces delisting from Nasdaq Agile Therapeutics stock soars on complete debt payoff Seeking Alpha’s Quant Rating on Agile Therapeutics Historical earnings data for Agile Therapeuti...

AGRX - Agile Therapeutics announces delisting from Nasdaq

2024-03-25 16:38:08 ET More on Agile Therapeutics Agile Therapeutics stock soars on complete debt payoff Agile Therapeutics reports higher prelim FY revenue than last year Seeking Alpha’s Quant Rating on Agile Therapeutics Historical earnings data for ...

Next 10